什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001009258
申报总市值
US$95.9亿
US$95.9亿
367 檔
23.6%
Q1 2024 季度申报显示,Deerfield Management Company, L.p. 披露的美股组合总市值为 US$95.9亿,涵盖 367 个不同之权益投资仓位。
在 Q1 2024,Deerfield Management Company, L.p. 操作展现出积极扩展与加仓意向。本季共新建仓 17 个新仓位,并对 13 个既有持股进行加仓(合计增持 30 档),相较减仓与清仓仓位显著占优。
在资产配置集中度方面,Deerfield Management Company, L.p. 的前 5 大核心持股(包含 NUVL, VTRS, CNC 等)合计占整体申报市值的 23.6%,反映机构在主要关键仓位上的权重分布。
仅显示前 200 大持股(共 367 只)
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc-a | 股票-其他 | 26.12% | +1.37% | — | |
| 2 | VTRS | Viatris Inc | 股票-医疗保健 | 4.44% | +0.13% | +7.71% | |
| 3 | CNC | Centene CORP | 股票-医疗保健 | 3.25% | +0.99% | +19.54% | |
| 4 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 2.80% | -0.76% | +25.33% | |
| 5 | BKD 2 10-15-26债券 | Brookdale Senior Living | 债券 | 2.76% | — | +10.93% | |
| 6 | AHCO | Adapthealth CORP | 股票-其他 | 2.65% | -0.36% | -2.57% | |
| 7 | CPRX | Catalyst Pharmaceuticals Inc | 股票-医疗保健 | 2.53% | -1.15% | EXIT | |
| 8 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 2.42% | — | -16.66% | |
| 9 | ✓ | Fusion Pharmaceuticals Inc | 股票-其他 | 2.37% | — | — | |
| 10 | ACH | Accendra Health Inc | 股票-其他 | 2.35% | — | -6.73% | |
| 11 | INSM 1.75 01-15-25债券 | Insmed Inc | 债券 | 2.16% | — | — | |
| 12 | ✓ | Merus N V | 股票-其他 | 2.08% | — | -12.27% | |
| 13 | ACCD 0.5 04-01-26债券 | Accolade Inc | 债券 | 2.04% | — | — | |
| 14 | KURA | Kura Oncology Inc | 股票-其他 | 2.01% | — | +1.86% | |
| 15 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 2.01% | +0.46% | — | |
| 16 | SPRY | Ars Pharmaceuticals Inc | 股票-其他 | 1.97% | -0.08% | — | |
| 17 | BKD | Brookdale Senior Living Inc | 股票-其他 | 1.80% | +0.07% | +5.54% | |
| 18 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 1.73% | +2.03% | — | |
| 19 | IART 0.5 08-15-25债券 | Integra Lifesciences Hld | 债券 | 1.72% | — | — | |
| 20 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.66% | -0.95% | EXIT | |
| 21 | SGRY | Surgery Partners Inc | 股票-其他 | 1.65% | — | +51.36% | |
| 22 | DCPHEUR | Deciphera Pharmaceuticals In | 股票-其他 | 1.40% | — | -11.42% | |
| 23 | ✓ | Hillevax Inc | 股票-其他 | 1.16% | — | — | |
| 24 | SWTXUSD | Springworks Therapeutics Inc | 股票-其他 | 1.10% | — | -50.35% | |
| 25 | EHABUSD | Enhabit Inc | 股票-其他 | 1.01% | -0.79% | EXIT | |
| 26 | NKTX | Nkarta Inc | 股票-其他 | 0.98% | — | +52.77% | |
| 27 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 0.92% | -0.05% | +0.53% | |
| 28 | BNTX | Biontech Se-adr | 股票-其他 | 0.91% | — | — | |
| 29 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.91% | — | -26.91% | |
| 30 | IART | Integra Lifesciences Holding | 股票-其他 | 0.91% | — | +30.48% | |
| 31 | LKFT | Lakefront Biotherapeutic-adr | 股票-其他 | 0.79% | — | +126.81% | |
| 32 | GPCR | Structure Therapeutics Inc | 股票-其他 | 0.77% | +0.17% | +25.63% | |
| 33 | IRON | Disc Medicine Inc | 股票-其他 | 0.72% | — | +43.34% | |
| 34 | ALHC | Alignment Healthcare Inc | 股票-其他 | 0.71% | — | +137.06% | |
| 35 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 0.66% | — | -63.76% | |
| 36 | KYTX | Kyverna Therapeutics Inc | 股票-其他 | 0.63% | -0.01% | — | |
| 37 | EMBC | Embecta CORP | 股票-医疗保健 | 0.63% | -0.17% | +96.86% | |
| 38 | ISREUR | Isoray Inc | 股票-其他 | 0.58% | — | — | |
| 39 | SLDB | Solid Biosciences Inc | 股票-其他 | 0.52% | — | — | |
| 40 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.51% | -0.94% | EXIT | |
| 41 | LNTH 2.625 12-15-27债券 | Lantheus Holdings Inc | 债券 | 0.49% | — | — | |
| 42 | CNMD | Conmed CORP | 股票-其他 | 0.47% | — | +13130.24% | |
| 43 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.44% | -0.12% | +10.03% | |
| 44 | INMD | InMode Ltd. | 股票-其他 | 0.44% | — | — | |
| 45 | ACCDUSD | Accolade Inc | 股票-其他 | 0.43% | — | — | |
| 46 | PHVS | Pharvaris N.V. | 股票-其他 | 0.43% | +0.18% | +30.70% | |
| 47 | AUTL | Autolus Therapeutics PLC | 股票-其他 | 0.40% | — | — | |
| 48 | APGE | Apogee Therapeutics Inc | 股票-其他 | 0.38% | — | — | |
| 49 | CABA | Cabaletta Bio Inc | 股票-其他 | 0.37% | — | -37.31% | |
| 50 | DCGO | Docgo Inc | 股票-其他 | 0.36% | — | -4.06% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | IART 0.5 08-15-25债券 | Integra Lifesciences Hld | +1.7% | NEW | 新建仓 |
| 2 | LRMR | Larimar Therapeutics Inc | +1.4% | +25.33% | 加仓 |
| 3 | ✓ | Fusion Pharmaceuticals Inc | +1.2% | — | 不变 |
| 4 | BNTX | Biontech Se-adr | +0.9% | NEW | 新建仓 |
| 5 | SPRY | Ars Pharmaceuticals Inc | +0.9% | — | 不变 |
| 6 | AHCO | Adapthealth CORP | +0.8% | -2.57% | 减仓 |
| 7 | KYTX | Kyverna Therapeutics Inc | +0.6% | NEW | 新建仓 |
| 8 | KURA | Kura Oncology Inc | +0.6% | +1.86% | 加仓 |
| 9 | ISREUR | Isoray Inc | +0.6% | NEW | 新建仓 |
| 10 | NKTX | Nkarta Inc | +0.6% | +52.77% | 加仓 |
| 11 | ✓ | Merus N V | +0.6% | -12.27% | 减仓 |
| 12 | CNC | Centene CORP | +0.5% | +19.54% | 加仓 |
| 13 | OSCR | Oscar Health Inc - Class A | +0.5% | -16.66% | 减仓 |
| 14 | SLDB | Solid Biosciences Inc | +0.5% | NEW | 新建仓 |
| 15 | ACH | Accendra Health Inc | +0.5% | -6.73% | 减仓 |
| 16 | LNTH 2.625 12-15-27债券 | Lantheus Holdings Inc | +0.5% | NEW | 新建仓 |
| 17 | VTRS | Viatris Inc | +0.5% | +7.71% | 加仓 |
| 18 | CNMD | Conmed CORP | +0.5% | +13130.24% | 加仓 |
| 19 | INMD | InMode Ltd. | +0.4% | NEW | 新建仓 |
| 20 | ACCDUSD | Accolade Inc | +0.4% | NEW | 新建仓 |
| 21 | SGRY | Surgery Partners Inc | +0.4% | +51.36% | 加仓 |
| 22 | AUTL | Autolus Therapeutics PLC | +0.4% | NEW | 新建仓 |
| 23 | APGE | Apogee Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 24 | VTYXUSD | Ventyx Biosciences Inc | +0.3% | NEW | 新建仓 |
| 25 | CGEM | Cullinan Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 26 | LKFT | Lakefront Biotherapeutic-adr | +0.3% | +126.81% | 加仓 |
| 27 | BKD 2 10-15-26债券 | Brookdale Senior Living | +0.3% | +10.93% | 加仓 |
| 28 | IDYA | Ideaya Biosciences Inc | +0.3% | — | 不变 |
| 29 | FATE | Fate Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 30 | NAMS | NewAmsterdam Pharma Company N.V. | +0.3% | NEW | 新建仓 |
| 31 | LNTH | Lantheus Holdings Inc | +0.3% | NEW | 新建仓 |
| 32 | ✓ | Engene Holdings Inc | +0.2% | NEW | 新建仓 |
| 33 | IRON | Disc Medicine Inc | +0.2% | +43.34% | 加仓 |
| 34 | VKTX | Viking Therapeutics Inc | +0.2% | -63.76% | 减仓 |
| 35 | BKD | Brookdale Senior Living Inc | +0.2% | +5.54% | 加仓 |
| 36 | EYPT | Eyepoint Inc | +0.2% | NEW | 新建仓 |
| 37 | ALHC | Alignment Healthcare Inc | +0.2% | +137.06% | 加仓 |
| 38 | GPCR | Structure Therapeutics Inc | +0.2% | +25.63% | 加仓 |
| 39 | RVMD | Revolution Medicines Inc | +0.1% | — | 不变 |
| 40 | DCPHEUR | Deciphera Pharmaceuticals In | -0.3% | -11.42% | 减仓 |
| 41 | PODD | Insulet CORP | -0.4% | -38.49% | 减仓 |
| 42 | CABA | Cabaletta Bio Inc | -0.5% | -37.31% | 减仓 |
| 43 | NBIX | Neurocrine Biosciences Inc | -0.5% | -22.94% | 减仓 |
| 44 | SWTXUSD | Springworks Therapeutics Inc | -0.6% | -50.35% | 减仓 |
| 45 | BAX | Baxter International Inc | -1% | -99.55% | 减仓 |
| 46 | NUVL | Nuvalent Inc-a | -1% | — | 不变 |
| 47 | ✓ | Rayzebio Inc | -1.2% | EXIT | 清仓 |
| 48 | NTRA 2.25 05-01-27债券 | Natera Inc | -3.2% | EXIT | 清仓 |
| 49 | NVTA 4.5 03-15-28 A债券 | Invitae CORP | -3.5% | EXIT | 清仓 |
| 50 | GKOS 2.75 06-15-27债券 | Glaukos CORP | -7.7% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案,Deerfield Management Company, L.p. 在 Q1 2024 季度的美股持仓总市值约为 US$95.9亿,共申报了 367 个公开持股仓位。
在 Q1 2024 季度,Deerfield Management Company, L.p. 按市值排列的前三大核心持股分别为:NUVL (26.1%)、VTRS (4.4%)、CNC (3.3%)。其中最大持股仓位 NUVL 占据整体投资组合约 26.1% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
IART 0.5 08-15-25
市值: US$9873.5万
本季最大获利了结 / 清仓标的
GKOS 2.75 06-15-27
前期市值: US$4.1亿
在 Q1 2024 季度中,Deerfield Management Company, L.p. 共进行了 45 项持仓异动,包含新建仓 17 个仓位、加仓 13 个仓位、减仓 11 个仓位以及清仓 4 个仓位。 其中最大新建仓标的为 IART 0.5 08-15-25。 本季清仓仓位包含 GKOS 2.75 06-15-27。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。